:: Library Catalog

Copertina

Salvato in:

Dettagli Bibliografici
Autori principali:	Daniel Backenroth, Ting Ye
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Statistics in Medicine
Accesso online:	https://onlinelibrary.wiley.com/doi/10.1002/sim.70577
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Improve the Precision of Area Under the Curve Estimation for Recurrent Events Through Covariate Adjustment
di: Jiren Sun, et al.
Pubblicazione: (2025)

Regression Adjustment in Covariate‐Adaptive Randomized Experiments With Missing Covariates
di: Wanjia Fu, et al.
Pubblicazione: (2025)

The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints
di: Xinran Huang, et al.
Pubblicazione: (2024)

Response‐Adaptive Randomization Procedure in Clinical Trials with Surrogate Endpoints
di: Jingya Gao, et al.
Pubblicazione: (2024)

Exact Randomized Two‐Stage Phase 2 Clinical Trial Designs for Two Binary Co‐Primary Endpoints
di: Hyejung Jung, et al.
Pubblicazione: (2026)

Statistical Inference for a Two‐Stage Adaptive Seamless Design Using Different Binary Endpoints
di: Ryota Ishii, et al.
Pubblicazione: (2025)

On Inclusion of Covariates in Model Based Dose Finding Clinical Trial Designs
di: Adrien Ollier, et al.
Pubblicazione: (2025)

Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches
di: Xiaotian Chen, et al.
Pubblicazione: (2025)

Sample Size Adjustment in Sequential Multiple Assignment Randomized Trials
di: Liwen Wu, et al.
Pubblicazione: (2025)

Dynamic Borrowing From Historical Controls via the Synthetic Prior With Covariates in Randomized Clinical Trials
di: Daniel E. Schwartz, et al.
Pubblicazione: (2026)

Adaptive Biomarker‐Based Design for Early Phase Clinical Trials
di: Alessandra Serra, et al.
Pubblicazione: (2025)

Bayesian Prediction of Event Times Using Mixture Model for Blinded Randomized Controlled Trials
di: Jingyan Fu, et al.
Pubblicazione: (2025)

A Unified Approach to Covariate Adjustment for Survival Endpoints in Randomized Clinical Trials
di: Zhiwei Zhang, et al.
Pubblicazione: (2025)

Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance
di: David S. Robertson, et al.
Pubblicazione: (2025)

Efficient Risk Assessment of Time‐to‐Event Targets With Adaptive Information Transfer
di: Jie Ding, et al.
Pubblicazione: (2024)

Adaptive Weight Selection for Time‐To‐Event Data Under Non‐Proportional Hazards
di: Moritz Fabian Danzer, et al.
Pubblicazione: (2025)

Sequential Parallel Comparison Design for Assessing Induction, Maintenance, Long‐Term, and Other Treatment Effects on a Binary Endpoint
di: Hui Quan, et al.
Pubblicazione: (2026)

A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards
di: Florian Klinglmüller, et al.
Pubblicazione: (2025)

Dual‐Criterion Approach Incorporating Historical Information to Seek Accelerated Approval With Application in Time‐to‐Event Group Sequential Trials
di: Marco Ratta, et al.
Pubblicazione: (2026)

Sample Size and Power Calculations With Win Measures Based on Hierarchical Endpoints
di: Huiman Barnhart, et al.
Pubblicazione: (2025)

A Note on the Sample Size Formula for a Win Ratio Endpoint
di: Se Yoon Lee
Pubblicazione: (2025)

Negative Control Outcome Adjustment in Early‐Phase Randomized Trials: Estimating Vaccine Effects on Immune Responses in HIV Exposed Uninfected Infants
di: Ethan Ashby, et al.
Pubblicazione: (2025)

A Nonparametric Global Win Probability Approach to the Analysis and Sizing of Randomized Controlled Trials With Multiple Endpoints of Different Scales and Missing Data: Beyond O'Brien–Wei–Lachin
di: Guangyong Zou, et al.
Pubblicazione: (2024)

Multivariate Adjustments for Average Equivalence Testing
di: Younes Boulaguiem, et al.
Pubblicazione: (2025)

Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo
di: Fei Gao, et al.
Pubblicazione: (2025)

The Design of Large‐Scale Plasma Donation Trials
di: Kecheng Li, et al.
Pubblicazione: (2025)

Two‐Stage Double‐Arm Trial Optimal Design of Restricted Mean Survival Time With Sculpted Critical Region
di: Jiashan He, et al.
Pubblicazione: (2026)

Bayesian Response‐Adaptive Randomization for Cluster Randomized Controlled Trials
di: Yunyi Liu, et al.
Pubblicazione: (2026)

Analysis of Covariance in General Factorial Designs Through Multiple Contrast Tests Under Variance Heteroscedasticity
di: Matthias Becher, et al.
Pubblicazione: (2025)

Safety‐Driven Response Adaptive Randomization: An Application in Noninferiority Oncology Trials
di: Maria Vittoria Chiaruttini, et al.
Pubblicazione: (2026)

Cluster‐Level Analyses to Estimate a Risk Difference in a Cluster Randomized Trial With Confounding Individual‐Level Covariates: A Simulation Study
di: Jules Antoine Pereira Macedo, et al.
Pubblicazione: (2025)

Robust Heterogeneity Adjustment for Gaussian Graphical Model With Latent Variables
di: Linxi Li, et al.
Pubblicazione: (2026)

Bayesian Ordered Lattice Design for Phase I Clinical Trials
di: Gi‐Ming Wang, et al.
Pubblicazione: (2026)

Preference‐Informed Cluster Randomized Design for Pragmatic Clinical Trials
di: Yuwei Cheng, et al.
Pubblicazione: (2026)

Design and Analysis of N‐Of‐1 Trials That Incorporate Sequential Monitoring
di: Shu Jiang, et al.
Pubblicazione: (2025)

Balancing Events, Not Patients, Maximizes Power of the Logrank Test: And Other Insights on Unequal Randomization in Survival Trials
di: Godwin Yung, et al.
Pubblicazione: (2025)

Covariate Balancing With Measurement Error
di: Xialing Wen, et al.
Pubblicazione: (2025)

Network Meta‐Analysis With Individual Participant‐Level Data of Time‐to‐Event Outcomes Using Cox Regression
di: Kaiyuan Hua, et al.
Pubblicazione: (2025)

A Biomarker‐Based Dose–Schedule Optimization Design for Immunotherapy Trials
di: Yingjie Qiu, et al.
Pubblicazione: (2026)

A Biomarker Signature‐Guided Clinical Trial Design for Precision Medicine
di: Yuan Li, et al.
Pubblicazione: (2025)